CHIEF EXECUTIVE OFFICER
Thu, Aug 15, 2024
Aug 15
11,687 shares @ $0.00
Decreased holdings by -7.10%
Net across this filing: +10.40% (+9,318 shares)
74th largest trade (out of 185)
Option ExercisePositive 90D History
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +10.4% (+9,318 shares)
64% win rate · +2.3% median edge vs SPY (14 trades, 90-day · small sample)
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology